Immediate Impact
32 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Works of Yashashwi Sinha being referenced
Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yashashwi Sinha | 29 | 40 | 26 | 42 | 20 | 169 | |
| Claudia Alejandra Pereda | 18 | 75 | 15 | 31 | 22 | 258 | |
| Mingzhen Yuan | 57 | 53 | 16 | 76 | 26 | 255 | |
| Andrej Starc | 21 | 42 | 38 | 40 | 16 | 239 | |
| Romain Boissier | 30 | 66 | 67 | 59 | 15 | 276 | |
| Veronica Brusi | 16 | 41 | 7 | 37 | 18 | 256 | |
| Corinne Praska | 16 | 11 | 22 | 35 | 18 | 223 | |
| Lei Tang | 22 | 21 | 8 | 44 | 21 | 208 | |
| Nimet Göker | 34 | 47 | 56 | 21 | 25 | 264 | |
| John Gannon | 21 | 50 | 49 | 78 | 17 | 263 | |
| Giovanni Maria Fusco | 8 | 29 | 21 | 16 | 23 | 139 |
All Works
Login with ORCID to disown or claim papers
Loading papers...